Global Injectable Drugs Delivery Industry

NEW YORK, Jan. 20, 2020 /PRNewswire/ --

Injectable Drugs Delivery market worldwide is projected to grow by US$423.4 Billion, driven by a compounded growth of 11%. Device, one of the segments analyzed and sized in this study, displays the potential to grow at over 6.9%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$172.8 Billion by the year 2025, Device will bring in healthy gains adding significant momentum to global growth.

Read the full report: https://www.reportlinker.com/p05798896/?utm_source=PRN

- Representing the developed world, the United States will maintain a 12.5% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$20.1 Billion to the region's size and clout in the next 5 to 6 years. Over US$19.4 Billion worth of projected demand in the region will come from Rest of Europe markets. In Japan, Device will reach a market size of US$17 Billion by the close of the analysis period. As the world's second largest economy and the new game changer in global markets, China exhibits the potential to grow at 10.7% over the next couple of years and add approximately US$73.8 Billion in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

- Competitors identified in this market include, among others, Baxter International, Inc.; Becton, Dickinson and Company; Elcam Medical; Eli Lilly and Company; Gerresheimer AG; INJEX Pharma GmbH; Novartis International AG; Novo Nordisk A/S; SCHOTT AG; Terumo Corporation; Teva Pharmaceuticals USA, Inc.; West Pharmaceutical Services, Inc.



Read the full report: https://www.reportlinker.com/p05798896/?utm_source=PRN

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Global Competitor Market Shares
Injectable Drugs Delivery Competitor Market Share Scenario
Worldwide (in %): 2019 & 2025
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
Table 1: Injectable Drugs Delivery Global Market Estimates and
Forecasts in US$ Million by Region/Country: 2018-2025
Table 2: Injectable Drugs Delivery Global Retrospective Market
Scenario in US$ Million by Region/Country: 2009-2017
Table 3: Injectable Drugs Delivery Market Share Shift across
Key Geographies Worldwide: 2009 VS 2019 VS 2025
Table 4: Device (Segment) World Market by Region/Country in US$
Million: 2018 to 2025
Table 5: Device (Segment) Historic Market Analysis by
Region/Country in US$ Million: 2009 to 2017
Table 6: Device (Segment) Market Share Breakdown of Worldwide
Sales by Region/Country: 2009 VS 2019 VS 2025
Table 7: Formulation (Segment) Potential Growth Markets
Worldwide in US$ Million: 2018 to 2025
Table 8: Formulation (Segment) Historic Market Perspective by
Region/Country in US$ Million: 2009 to 2017
Table 9: Formulation (Segment) Market Sales Breakdown by
Region/Country in Percentage: 2009 VS 2019 VS 2025
Table 10: Hospitals & Clinics (End-Use) Global Market Estimates
& Forecasts in US$ Million by Region/Country: 2018-2025
Table 11: Hospitals & Clinics (End-Use) Retrospective Demand
Analysis in US$ Million by Region/Country: 2009-2017
Table 12: Hospitals & Clinics (End-Use) Market Share Breakdown
by Region/Country: 2009 VS 2019 VS 2025
Table 13: Home Care (End-Use) Demand Potential Worldwide in US$
Million by Region/Country: 2018-2025
Table 14: Home Care (End-Use) Historic Sales Analysis in US$
Million by Region/Country: 2009-2017
Table 15: Home Care (End-Use) Share Breakdown Review by
Region/Country: 2009 VS 2019 VS 2025
Table 16: Research Laboratories (End-Use) Worldwide Latent
Demand Forecasts in US$ Million by Region/Country: 2018-2025
Table 17: Research Laboratories (End-Use) Global Historic
Analysis in US$ Million by Region/Country: 2009-2017
Table 18: Research Laboratories (End-Use) Distribution of
Global Sales by Region/Country: 2009 VS 2019 VS 2025
Table 19: Other End-Uses (End-Use) Sales Estimates and
Forecasts in US$ Million by Region/Country for the Years 2018
through 2025
Table 20: Other End-Uses (End-Use) Analysis of Historic Sales
in US$ Million by Region/Country for the Years 2009 to 2017
Table 21: Other End-Uses (End-Use) Global Market Share
Distribution by Region/Country for 2009, 2019, and 2025

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS
UNITED STATES
Market Facts & Figures
US Injectable Drugs Delivery Market Share (in %) by Company:
2019 & 2025
Table 22: United States Injectable Drugs Delivery Market
Estimates and Projections in US$ Million by Segment: 2018 to
2025
Table 23: Injectable Drugs Delivery Market in the United States
by Segment: A Historic Review in US$ Million for 2009-2017
Table 24: United States Injectable Drugs Delivery Market Share
Breakdown by Segment: 2009 VS 2019 VS 2025
Table 25: United States Injectable Drugs Delivery Latent Demand
Forecasts in US$ Million by End-Use: 2018 to 2025
Table 26: Injectable Drugs Delivery Historic Demand Patterns in
the United States by End-Use in US$ Million for 2009-2017
Table 27: Injectable Drugs Delivery Market Share Breakdown in
the United States by End-Use: 2009 VS 2019 VS 2025
CANADA
Table 28: Canadian Injectable Drugs Delivery Market Estimates
and Forecasts in US$ Million by Segment: 2018 to 2025
Table 29: Canadian Injectable Drugs Delivery Historic Market
Review by Segment in US$ Million: 2009-2017
Table 30: Injectable Drugs Delivery Market in Canada:
Percentage Share Breakdown of Sales by Segment for 2009, 2019,
and 2025
Table 31: Canadian Injectable Drugs Delivery Market
Quantitative Demand Analysis in US$ Million by End-Use: 2018 to
2025
Table 32: Injectable Drugs Delivery Market in Canada:
Summarization of Historic Demand Patterns in US$ Million by
End-Use for 2009-2017
Table 33: Canadian Injectable Drugs Delivery Market Share
Analysis by End-Use: 2009 VS 2019 VS 2025
JAPAN
Table 34: Japanese Market for Injectable Drugs Delivery: Annual
Sales Estimates and Projections in US$ Million by Segment for
the Period 2018-2025
Table 35: Injectable Drugs Delivery Market in Japan: Historic
Sales Analysis in US$ Million by Segment for the Period
2009-2017
Table 36: Japanese Injectable Drugs Delivery Market Share
Analysis by Segment: 2009 VS 2019 VS 2025
Table 37: Japanese Demand Estimates and Forecasts for
Injectable Drugs Delivery in US$ Million by End-Use: 2018 to
2025
Table 38: Japanese Injectable Drugs Delivery Market in US$
Million by End-Use: 2009-2017
Table 39: Injectable Drugs Delivery Market Share Shift in Japan
by End-Use: 2009 VS 2019 VS 2025
CHINA
Table 40: Chinese Injectable Drugs Delivery Market Growth
Prospects in US$ Million by Segment for the Period 2018-2025
Table 41: Injectable Drugs Delivery Historic Market Analysis in
China in US$ Million by Segment: 2009-2017
Table 42: Chinese Injectable Drugs Delivery Market by Segment:
Percentage Breakdown of Sales for 2009, 2019, and 2025
Table 43: Chinese Demand for Injectable Drugs Delivery in US$
Million by End-Use: 2018 to 2025
Table 44: Injectable Drugs Delivery Market Review in China in
US$ Million by End-Use: 2009-2017
Table 45: Chinese Injectable Drugs Delivery Market Share
Breakdown by End-Use: 2009 VS 2019 VS 2025
EUROPE
Market Facts & Figures
European Injectable Drugs Delivery Market: Competitor Market
Share Scenario (in %) for 2019 & 2025
Table 46: European Injectable Drugs Delivery Market Demand
Scenario in US$ Million by Region/Country: 2018-2025
Table 47: Injectable Drugs Delivery Market in Europe: A
Historic Market Perspective in US$ Million by Region/Country
for the Period 2009-2017
Table 48: European Injectable Drugs Delivery Market Share Shift
by Region/Country: 2009 VS 2019 VS 2025
Table 49: European Injectable Drugs Delivery Market Estimates
and Forecasts in US$ Million by Segment: 2018-2025
Table 50: Injectable Drugs Delivery Market in Europe in US$
Million by Segment: A Historic Review for the Period 2009-2017
Table 51: European Injectable Drugs Delivery Market Share
Breakdown by Segment: 2009 VS 2019 VS 2025
Table 52: European Injectable Drugs Delivery Addressable Market
Opportunity in US$ Million by End-Use: 2018-2025
Table 53: Injectable Drugs Delivery Market in Europe:
Summarization of Historic Demand in US$ Million by End-Use for
the Period 2009-2017
Table 54: European Injectable Drugs Delivery Market Share
Analysis by End-Use: 2009 VS 2019 VS 2025
FRANCE
Table 55: Injectable Drugs Delivery Market in France by
Segment: Estimates and Projections in US$ Million for the
Period 2018-2025
Table 56: French Injectable Drugs Delivery Historic Market
Scenario in US$ Million by Segment: 2009-2017
Table 57: French Injectable Drugs Delivery Market Share
Analysis by Segment: 2009 VS 2019 VS 2025
Table 58: Injectable Drugs Delivery Quantitative Demand
Analysis in France in US$ Million by End-Use: 2018-2025
Table 59: French Injectable Drugs Delivery Historic Market
Review in US$ Million by End-Use: 2009-2017
Table 60: French Injectable Drugs Delivery Market Share
Analysis: A 17-Year Perspective by End-Use for 2009, 2019, and
2025
GERMANY
Table 61: Injectable Drugs Delivery Market in Germany: Recent
Past, Current and Future Analysis in US$ Million by Segment for
the Period 2018-2025
Table 62: German Injectable Drugs Delivery Historic Market
Analysis in US$ Million by Segment: 2009-2017
Table 63: German Injectable Drugs Delivery Market Share
Breakdown by Segment: 2009 VS 2019 VS 2025
Table 64: Injectable Drugs Delivery Market in Germany: Annual
Sales Estimates and Forecasts in US$ Million by End-Use for the
Period 2018-2025
Table 65: German Injectable Drugs Delivery Market in Retrospect
in US$ Million by End-Use: 2009-2017
Table 66: Injectable Drugs Delivery Market Share Distribution
in Germany by End-Use: 2009 VS 2019 VS 2025
ITALY
Table 67: Italian Injectable Drugs Delivery Market Growth
Prospects in US$ Million by Segment for the Period 2018-2025
Table 68: Injectable Drugs Delivery Historic Market Analysis in
Italy in US$ Million by Segment: 2009-2017
Table 69: Italian Injectable Drugs Delivery Market by Segment:
Percentage Breakdown of Sales for 2009, 2019, and 2025
Table 70: Italian Demand for Injectable Drugs Delivery in US$
Million by End-Use: 2018 to 2025
Table 71: Injectable Drugs Delivery Market Review in Italy in
US$ Million by End-Use: 2009-2017
Table 72: Italian Injectable Drugs Delivery Market Share
Breakdown by End-Use: 2009 VS 2019 VS 2025
UNITED KINGDOM
Table 73: United Kingdom Market for Injectable Drugs Delivery:
Annual Sales Estimates and Projections in US$ Million by
Segment for the Period 2018-2025
Table 74: Injectable Drugs Delivery Market in the United
Kingdom: Historic Sales Analysis in US$ Million by Segment for
the Period 2009-2017
Table 75: United Kingdom Injectable Drugs Delivery Market Share
Analysis by Segment: 2009 VS 2019 VS 2025
Table 76: United Kingdom Demand Estimates and Forecasts for
Injectable Drugs Delivery in US$ Million by End-Use: 2018 to
2025
Table 77: United Kingdom Injectable Drugs Delivery Market in
US$ Million by End-Use: 2009-2017
Table 78: Injectable Drugs Delivery Market Share Shift in the
United Kingdom by End-Use: 2009 VS 2019 VS 2025
REST OF EUROPE
Table 79: Rest of Europe Injectable Drugs Delivery Market
Estimates and Forecasts in US$ Million by Segment: 2018-2025
Table 80: Injectable Drugs Delivery Market in Rest of Europe in
US$ Million by Segment: A Historic Review for the Period
2009-2017
Table 81: Rest of Europe Injectable Drugs Delivery Market Share
Breakdown by Segment: 2009 VS 2019 VS 2025
Table 82: Rest of Europe Injectable Drugs Delivery Addressable
Market Opportunity in US$ Million by End-Use: 2018-2025
Table 83: Injectable Drugs Delivery Market in Rest of Europe:
Summarization of Historic Demand in US$ Million by End-Use for
the Period 2009-2017
Table 84: Rest of Europe Injectable Drugs Delivery Market Share
Analysis by End-Use: 2009 VS 2019 VS 2025
ASIA-PACIFIC
Table 85: Injectable Drugs Delivery Market in Asia-Pacific by
Segment: Estimates and Projections in US$ Million for the
Period 2018-2025
Table 86: Asia-Pacific Injectable Drugs Delivery Historic
Market Scenario in US$ Million by Segment: 2009-2017
Table 87: Asia-Pacific Injectable Drugs Delivery Market Share
Analysis by Segment: 2009 VS 2019 VS 2025
Table 88: Injectable Drugs Delivery Quantitative Demand
Analysis in Asia-Pacific in US$ Million by End-Use: 2018-2025
Table 89: Asia-Pacific Injectable Drugs Delivery Historic
Market Review in US$ Million by End-Use: 2009-2017
Table 90: Asia-Pacific Injectable Drugs Delivery Market Share
Analysis: A 17-Year Perspective by End-Use for 2009, 2019, and
2025
REST OF WORLD
Table 91: Rest of World Injectable Drugs Delivery Market
Estimates and Forecasts in US$ Million by Segment: 2018 to 2025
Table 92: Rest of World Injectable Drugs Delivery Historic
Market Review by Segment in US$ Million: 2009-2017
Table 93: Injectable Drugs Delivery Market in Rest of World:
Percentage Share Breakdown of Sales by Segment for 2009, 2019,
and 2025
Table 94: Rest of World Injectable Drugs Delivery Market
Quantitative Demand Analysis in US$ Million by End-Use: 2018 to
2025
Table 95: Injectable Drugs Delivery Market in Rest of World:
Summarization of Historic Demand Patterns in US$ Million by
End-Use for 2009-2017
Table 96: Rest of World Injectable Drugs Delivery Market Share
Analysis by End-Use: 2009 VS 2019 VS 2025

IV. COMPETITION

BAXTER INTERNATIONAL
ELCAM MEDICAL
ELI LILLY AND COMPANY
GERRESHEIMER AG
INJEX PHARMA GMBH
NOVARTIS INTERNATIONAL AG
NOVO NORDISK A/S
SCHOTT AG
TERUMO CORPORATION
TEVA PHARMACEUTICALS USA
WEST PHARMACEUTICAL SERVICES

V. CURATED RESEARCH
Read the full report: https://www.reportlinker.com/p05798896/?utm_source=PRN

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001

View original content:http://www.prnewswire.com/news-releases/global-injectable-drugs-delivery-industry-300989508.html

SOURCE Reportlinker